E-CEL PEC Trademark

Trademark Overview

On Tuesday, February 16, 2016, a trademark application was filed for E-CEL PEC with the United States Patent and Trademark Office. The USPTO has given the E-CEL PEC trademark a serial number of 86908707. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 27, 2024. This trademark is owned by Angiocrine Bioscience. The E-CEL PEC trademark is filed in the Pharmaceutical Products category with the following description:

Cells for medical or clinical use; stem cells for medical purposes; stem cells for veterinary purposes; cell growth media for growing cells for medical or clinical use; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of infectious diseases
e-cel pec

General Information

Serial Number86908707
Word MarkE-CEL PEC
Filing DateTuesday, February 16, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 27, 2024
Registration Number5423948
Registration DateTuesday, March 13, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 5, 2016

Trademark Statements

Goods and ServicesCells for medical or clinical use; stem cells for medical purposes; stem cells for veterinary purposes; cell growth media for growing cells for medical or clinical use; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of infectious diseases
NOT AVAILABLE"PEC"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 27, 2024
Primary Code005
First Use Anywhere DateThursday, December 31, 2015
First Use In Commerce DateThursday, December 31, 2015

Trademark Owner History

Party NameAngiocrine Bioscience
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92172
Party NameAngiocrine Bioscience
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92172
Party NameAngiocrine Bioscience
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92172

Trademark Events

Event DateEvent Description
Friday, February 19, 2016NEW APPLICATION ENTERED
Monday, February 22, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 15, 2016ASSIGNED TO EXAMINER
Friday, May 6, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, May 6, 2016EXAMINERS AMENDMENT E-MAILED
Friday, May 6, 2016EXAMINERS AMENDMENT -WRITTEN
Friday, May 6, 2016EXAMINER'S AMENDMENT ENTERED
Friday, May 6, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 11, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 15, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 11, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 24, 2016ASSIGNED TO LIE
Tuesday, May 31, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 5, 2016PUBLISHED FOR OPPOSITION
Wednesday, November 30, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 5, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 30, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 28, 2016SOU TEAS EXTENSION RECEIVED
Monday, November 28, 2016SOU EXTENSION 1 FILED
Monday, November 28, 2016SOU EXTENSION 1 GRANTED
Monday, August 28, 2017SOU TEAS EXTENSION RECEIVED
Monday, August 28, 2017SOU EXTENSION 2 FILED
Monday, August 28, 2017SOU EXTENSION 2 GRANTED
Wednesday, August 30, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 28, 2017TEAS STATEMENT OF USE RECEIVED
Thursday, December 28, 2017USE AMENDMENT FILED
Saturday, January 13, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, January 14, 2018STATEMENT OF USE PROCESSING COMPLETE
Friday, February 2, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, July 29, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 29, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 29, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 13, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, September 27, 2024CANCELLED SEC. 8 (6-YR)
Tuesday, March 13, 2018REGISTERED-PRINCIPAL REGISTER
Saturday, February 3, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

cells medical treatment pharmaceutical stem purposes clinical cancer diseases prevention